276 related articles for article (PubMed ID: 26874744)
1. Synthesis and cytotoxic activities of some pyrazoline derivatives bearing phenyl pyridazine core as new apoptosis inducers.
George RF; Fouad MA; Gomaa IEO
Eur J Med Chem; 2016 Apr; 112():48-59. PubMed ID: 26874744
[TBL] [Abstract][Full Text] [Related]
2. Development of pyridazine derivatives as potential EGFR inhibitors and apoptosis inducers: Design, synthesis, anticancer evaluation, and molecular modeling studies.
Ahmed MF; Santali EY; Mohi El-Deen EM; Naguib IA; El-Haggar R
Bioorg Chem; 2021 Jan; 106():104473. PubMed ID: 33243490
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of benzo[d][1,3]dioxol-5-yl chalcones as antiproliferating agents.
Kamal A; Balakrishna M; Loka Reddy V; Riyaz S; Bagul C; Satyanarayana BM; Venkateswar Rao J
Chem Biol Drug Des; 2015 Nov; 86(5):1267-84. PubMed ID: 26032623
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and QSAR study of 2'-hydroxy-4'-alkoxy chalcone derivatives that exert cytotoxic activity by the mitochondrial apoptotic pathway.
Marquina S; Maldonado-Santiago M; Sánchez-Carranza JN; Antúnez-Mojica M; González-Maya L; Razo-Hernández RS; Alvarez L
Bioorg Med Chem; 2019 Jan; 27(1):43-54. PubMed ID: 30482548
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Evaluation of Heterocycles Based Chalcone Derivatives as Antiproliferative Agents.
Çavuşoğlu BK; Atlı Ö; Görmüş G; Özkay Y; Kaplancıklı ZA
Anticancer Agents Med Chem; 2018; 18(7):1044-1053. PubMed ID: 29308744
[TBL] [Abstract][Full Text] [Related]
6. Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins.
Mai CW; Yaeghoobi M; Abd-Rahman N; Kang YB; Pichika MR
Eur J Med Chem; 2014 Apr; 77():378-87. PubMed ID: 24675137
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells.
Chauhan SS; Singh AK; Meena S; Lohani M; Singh A; Arya RK; Cheruvu SH; Sarkar J; Gayen JR; Datta D; Chauhan PM
Bioorg Med Chem Lett; 2014 Jul; 24(13):2820-4. PubMed ID: 24844196
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones.
Mohamed MF; Hassaneen HM; Abdelhamid IA
Eur J Med Chem; 2018 Jan; 143():532-541. PubMed ID: 29207336
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative activity and p53 upregulation effects of chalcones on human breast cancer cells.
Dos Santos MB; Bertholin Anselmo D; de Oliveira JG; Jardim-Perassi BV; Alves Monteiro D; Silva G; Gomes E; Lucia Fachin A; Marins M; de Campos Zuccari DAP; Octavio Regasini L
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1093-1099. PubMed ID: 31117836
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors.
Qin YJ; Li YJ; Jiang AQ; Yang MR; Zhu QZ; Dong H; Zhu HL
Eur J Med Chem; 2015 Apr; 94():447-57. PubMed ID: 25828827
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of a novel series of chalcones incorporated pyrazole moiety as anticancer and antimicrobial agents.
Mohamed MF; Mohamed MS; Shouman SA; Fathi MM; Abdelhamid IA
Appl Biochem Biotechnol; 2012 Nov; 168(5):1153-62. PubMed ID: 22948604
[TBL] [Abstract][Full Text] [Related]
12. A New Series of Cytotoxic Pyrazoline Derivatives as Potential Anticancer Agents that Induce Cell Cycle Arrest and Apoptosis.
Wang H; Zheng J; Xu W; Chen C; Wei D; Ni W; Pan Y
Molecules; 2017 Sep; 22(10):. PubMed ID: 28961210
[TBL] [Abstract][Full Text] [Related]
13. 3-Aminomethyl pyridine chalcone derivatives: Design, synthesis, DNA binding and cytotoxic studies.
Durgapal SD; Soni R; Umar S; Suresh B; Soman SS
Chem Biol Drug Des; 2018 Jul; 92(1):1279-1287. PubMed ID: 29575807
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents.
Wan M; Xu L; Hua L; Li A; Li S; Lu W; Pang Y; Cao C; Liu X; Jiao P
Bioorg Chem; 2014 Jun; 54():38-43. PubMed ID: 24747188
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Biological Evaluation of 1,2,3-triazole tethered Pyrazoline and Chalcone Derivatives.
Hussaini SM; Yedla P; Babu KS; Shaik TB; Chityal GK; Kamal A
Chem Biol Drug Des; 2016 Jul; 88(1):97-109. PubMed ID: 26854643
[TBL] [Abstract][Full Text] [Related]
16. Design and Synthesis of Pyridazine Containing Compounds with Promising Anticancer Activity.
Elmeligie S; Ahmed EM; Abuel-Maaty SM; Zaitone SA; Mikhail DS
Chem Pharm Bull (Tokyo); 2017; 65(3):236-247. PubMed ID: 28250345
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of halogenated phenoxychalcones and their corresponding pyrazolines as cytotoxic agents in human breast cancer.
Halim PA; Hassan RA; Mohamed KO; Hassanin SO; Khalil MG; Abdou AM; Osman EO
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):189-201. PubMed ID: 34894967
[TBL] [Abstract][Full Text] [Related]
18. Discovery of thiazole-based-chalcones and 4-hetarylthiazoles as potent anticancer agents: Synthesis, docking study and anticancer activity.
Farghaly TA; Masaret GS; Muhammad ZA; Harras MF
Bioorg Chem; 2020 May; 98():103761. PubMed ID: 32200332
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, in vitro Antiproliferative and Antiinflammatory Activities, and Kinase Inhibitory effects of New 1,3,4-triarylpyrazole Derivatives.
El-Gamal MI; Abdel-Maksoud MS; Gamal El-Din MM; Shin JS; Lee KT; Yoo KH; Oh CH
Anticancer Agents Med Chem; 2017; 17(1):75-84. PubMed ID: 27334850
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of chalcones with anticancer activities.
Syam S; Abdelwahab SI; Al-Mamary MA; Mohan S
Molecules; 2012 May; 17(6):6179-95. PubMed ID: 22634834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
